LitAlert ~~ GeneLit.com

    • Olaparib – cancer de prostate métastatique résistant à la castration muté BRCA [Drug approval: Olaparib - metastatic castration-resistant prostate cancer with BRCA mutation].
    • Saillant A, Flippot R.
    • Bull Cancer. 2021 Feb 2:S0007-4551(21)00015-1. French. doi: 10.1016/j.bulcan.2020.11.010. Epub ahead of print.
    • Letter, [Article in French]
    • Successful treatment of a patient with brain metastases from endometrial cancer using Niraparib: a case report.
    • Wang Q, Zhang F, Gao H, Xu Y.
    • Ann Palliat Med. 2021 Jan;10(1):818-827. doi: 10.21037/apm-21-113.